NPPB and coronary artery disorder: We evaluated five established biomarkers known to be affected by CAD: N-terminal pro-brain natriuretic peptide (NTproBNP) [8–10], high-sensitivity C-reactive protein (hsCRP) [11], cystatin C (CysC) [12, 13], myeloperoxidase (MPO) [14, 15] and high-sensitivity troponin I (hsTnI) [16, 17].